Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2341 AL 2355

The Contribution of Functional Near-Infrared Spectroscopy (fNIRS) to the Study of Neurodegenerative Disorders: A Narrative Review

Liampas I, Danga F, Kyriakoulopoulou P, Siokas V, Stamati P, Messinis L, Dardiotis E, Nasios G.

Diagnostics (Basel). 2024 Mar 21;14(6):663. doi: 10.3390/diagnostics14060663.

The Role of Vitamin K in the Development of Neurodegenerative Diseases

Diachenko AI, Rodin IA, Krasnova TN, Klychnikov OI, Nefedova LN.

Biochemistry (Mosc). 2024 Jan;89(Suppl 1):S57-S70. doi: 10.1134/S0006297924140049.

Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers

Anjo SI, He Z, Hussain Z, Farooq A, McIntyre A, Laughton CA, Carvalho AN, Finelli MJ.

Antioxidants (Basel). 2024 May 31;13(6):681. doi: 10.3390/antiox13060681.

Pharmacological Activities and Molecular Mechanisms of Sinapic Acid in Neurological Disorders

Farzan M, Abedi B, Bhia I, Madanipour A, Farzan M, Bhia M, Aghaei A, Kheirollahi I, Motallebi M, Amini-Khoei H, Ertas YN.

ACS Chem Neurosci. 2024 Aug 21;15(16):2966-2981. doi: 10.1021/acschemneuro.4c00349. Epub 2024 Jul 31.

Levodopa-induced dyskinesia: brain iron deposition as a new hypothesis

Zhang F, Ye Z, Xie Y, Liu M, Zhang L, Zhang J, Xu Z.

Biometals. 2024 Dec;37(6):1307-1323. doi: 10.1007/s10534-024-00628-8. Epub 2024 Aug 30.

A Survey on Computational Methods in Drug Discovery for Neurodegenerative Diseases

Vicidomini C, Fontanella F, D'Alessandro T, Roviello GN.

Biomolecules. 2024 Oct 19;14(10):1330. doi: 10.3390/biom14101330.

Purinergic Receptor (P2X7R): A Promising Anti-Parkinson's Drug Target

Magham S, Kumar ML, Krishnamurthy PT, Shaji N, Ramakkamma AR.

Adv Pharm Bull. 2024 Dec 30;14(4):807-818. doi: 10.34172/apb.43206. Epub 2024 Dec 18.

Polyphenols Targeting MAP Kinase Signaling Pathway in Neurological Diseases: Understanding Molecular Mechanisms and Therapeutic Targets

Islam F, Roy S, Zehravi M, Paul S, Sutradhar H, Yaidikar L, Kumar BR, Dogiparthi LK, Prema S, Nainu F, Rab SO, Doukani K, Emran TB.

Mol Neurobiol. 2024 May;61(5):2686-2706. doi: 10.1007/s12035-023-03706-z. Epub 2023 Nov 3.

EEG entropy insights in the context of physiological aging and Alzheimer's and Parkinson's diseases: a comprehensive review

Cacciotti A, Pappalettera C, Miraglia F, Rossini PM, Vecchio F.

Geroscience. 2024 Dec;46(6):5537-5557. doi: 10.1007/s11357-024-01185-1. Epub 2024 May 22.

Knowledge mapping of prodromal Parkinson's disease: A bibliometric review and analysis (2000-2023)

Wang S, An N, Wang Y, Li Y, Li H, Bai Y.

Medicine (Baltimore). 2024 Feb 2;103(5):e36985. doi: 10.1097/MD.0000000000036985.

Oxidative Stress and Dopaminergic Metabolism: A Major PD Pathogenic Mechanism and Basis of Potential Antioxidant Therapies

Rasool A, Manzoor R, Ullah K, Afzal R, Ul-Haq A, Imran H, Kaleem I, Akhtar T, Farrukh A, Hameed S, Bashir S.

CNS Neurol Disord Drug Targets. 2024;23(7):852-864. doi: 10.2174/1871527322666230609141519.

Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease

Matt RA, Martin RS, Evans AK, Gever JR, Vargas GA, Shamloo M, Ford AP.

Handb Exp Pharmacol. 2024;285:555-616. doi: 10.1007/164_2023_677.

Intestinal Barrier Function and Neurodegenerative Disease

Wu S, Yang L, Fu Y, Liao Z, Cai D, Liu Z.

CNS Neurol Disord Drug Targets. 2024;23(9):1134-1142. doi: 10.2174/0118715273264097231116103948.

The impact of the socioeconomic factor on Parkinson's disease medication adherence: a scoping review

Gil G, Tosin MHS, Ferraz HB.

Arq Neuropsiquiatr. 2024 Feb;82(2):1-8. doi: 10.1055/s-0044-1779608. Epub 2024 Feb 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias